Development and validation of the Treatment Related Impact Measure of Weight (TRIM-Weight)

被引:12
作者
Brod, Meryl [1 ]
Hammer, Mette [2 ]
Kragh, Nana [2 ]
Lessard, Suzanne [1 ]
Bushnell, Donald M. [3 ]
机构
[1] Brod Grp, Mill Valley, CA 94941 USA
[2] Novo Nordisk AS, Global Dev, DK-2880 Bagsvaerd, Denmark
[3] Hlth Res Associates, Mountlake Terrace, WA 98013 USA
关键词
QUALITY-OF-LIFE; PAPER-AND-PENCIL; TREATMENT SATISFACTION; OBESE-PATIENTS; HEALTH SURVEY; QUESTIONNAIRE; INSULIN; RELIABILITY; MEDICATION; MANAGEMENT;
D O I
10.1186/1477-7525-8-19
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: The use of prescription anti-obesity medication (AOM) is becoming increasingly common as treatment options grow and become more accessible. However, AOM may not be without a wide range of potentially negative impacts on patient functioning and well being. The Treatment Related Impact Measure (TRIM-Weight) is an obesity treatment-specific patient reported outcomes (PRO) measure designed to assess the key impacts of prescription anti-obesity medication. This paper will present the validation findings for the TRIM-Weight. Methods: The online validation battery survey was administered in four countries (the U. S., U. K., Australia, and Canada). Eligible subjects were over age eighteen, currently taking a prescription AOM and were currently or had been obese during their life. Validation analyses were conducted according to an a priori statistical analysis plan. Item level psychometric and conceptual criteria were used to refine and reduce the preliminary item pool and factor analysis to identify structural domains was performed. Reliability and validity testing was then performed and the minimally importance difference (MID) explored. Results: Two hundred and eight subjects completed the survey. Twenty-one of the 43 items were dropped and a five-factor structure was achieved: Daily Life, Weight Management, Treatment Burden, Experience of Side Effects, and Psychological Health. A-priori criteria for internal consistency and test-retest coefficients for the total score and all five subscales were met. All pre-specified hypotheses for convergent and known group validity were also met with the exception of the domain of Daily Life (proven in an ad hoc analysis) as well as the 1/2 standard deviation threshold for the MID. Conclusion: The development and validation of the TRIM-Weight has been conducted according to well-defined principles for the creation of a PRO measure. Based on the evidence to date, the TRIM-Weight can be considered a brief, conceptually sound, valid and reliable PRO measure.
引用
收藏
页数:11
相关论文
共 41 条
[1]  
Aaronson N, 2002, QUAL LIFE RES, V11, P193
[2]   Satisfaction as a determinant of compliance [J].
Albrecht, G ;
Hoogstraten, J .
COMMUNITY DENTISTRY AND ORAL EPIDEMIOLOGY, 1998, 26 (02) :139-146
[3]   Development and validation of the insulin treatment satisfaction questionnaire [J].
Anderson, RT ;
Skovlund, SE ;
Marrero, D ;
Levine, DW ;
Meadows, K ;
Brod, M ;
Balkrishnan, R .
CLINICAL THERAPEUTICS, 2004, 26 (04) :565-578
[4]  
Anderson RT, 2003, DIABETOLOGIA, V46, pA275
[5]  
[Anonymous], 2006, GUID IND PAT REP OUT
[6]   Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease [J].
Atkinson M.J. ;
Sinha A. ;
Hass S.L. ;
Colman S.S. ;
Kumar R.N. ;
Brod M. ;
Rowland C.R. .
Health and Quality of Life Outcomes, 2 (1)
[7]   Measuring outcomes following bariatric surgery: Weight loss parameters, improvement in co-morbid conditions, change in quality of life and patient satisfaction [J].
Ballantyne, GH .
OBESITY SURGERY, 2003, 13 (06) :954-964
[8]  
BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588
[9]   Validation of an abbreviated Treatment Satisfaction Questionnaire for Medication (TSQM-9) among patients on antihypertensive medications [J].
Bharmal, Murtuza ;
Payne, Krista ;
Atkinson, Mark J. ;
Desrosiers, Marie-Pierre ;
Morisky, Donald E. ;
Gemmen, Eric .
HEALTH AND QUALITY OF LIFE OUTCOMES, 2009, 7
[10]   UNDERSTANDING AND ASSESSING THE IMPACT OF PRESCRIPTION WEIGHT LOSS MEDICATION; CONCEPTUAL, GENDER AND CULTURAL ISSUES [J].
Brod, M. ;
Hammer, M. ;
Lessard, S. ;
Kragh, N. .
VALUE IN HEALTH, 2008, 11 (06) :A642-A643